Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Nasser Hashemi Goradel"'
Autor:
Mahdie Jafari, Maryam Kadkhodazadeh, Mina Bahrololoumi Shapourabadi, Nasser Hashemi Goradel, Mohammad Ali Shokrgozar, Arash Arashkia, Shahriyar Abdoli, Zahra Sharifzadeh
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Despite the fact that the new drugs and targeted therapies have been approved for cancer therapy during the past 30 years, the majority of cancer types are still remain challenging to be treated. Due to the tumor heterogeneity, immune system evasion
Externí odkaz:
https://doaj.org/article/e128eb23b2cc4925ac40e3c111df6b5d
Autor:
Ziba Veisi Malekshahi, Nasser Hashemi Goradel, Mehdi Shakouri Khomartash, Amir Maleksabet, Maryam kadkhodazadeh, Gholam Ali Kardar, Babak Negahdari
Publikováno v:
Iranian Journal of Immunology, Vol 16, Iss 3, Pp 235-245 (2019)
Background: Human colorectal cancer cells overexpress carcinoembryonic antigen (CEA). CEA is a glycoprotein which has shown to be a promising vaccine target for immunotherapy against colorectal cancer. Objective: To design a DNA vaccine harboring CEA
Externí odkaz:
https://doaj.org/article/1964133034fe4ce6bdca2e5169a7d68c
Publikováno v:
Advanced Pharmaceutical Bulletin, Vol 5, Iss 3, Pp 293-298 (2015)
Cell therapy is a promising intervention for treating liver diseases and liver failure. Different animal models of human liver cell therapy have been developed in recent years. Rats and mice are the most commonly used liver failure models. In fact, r
Externí odkaz:
https://doaj.org/article/e7e7a5ae234a4e8bb4c0bf17a3b2b656
Publikováno v:
International Immunopharmacology. 117:109887
Autor:
Esmail Fattahi, Nasser Hashemi Goradel, Hami Kaboosi, Nasim Ebrahimi, Babak Negahdari, Momeneh Ghanaat, Ziba Veisi Malekshahi, Sajjad Ghorghanlu, Arash Arashkia
Publikováno v:
Acta Pharmacol Sin
Although most human papillomavirus (HPV) infections are harmless, persistent infection with high-risk types of HPV is known to be the leading cause of cervical cancer. Following the infection of the epithelium and integration into the host genome, th
Autor:
Shahnaz Hosseinzadeh, Zeinab Ghesmati, Babak Negahdari, Arezoo Alizadeh, Arash Arashkia, Mitra Taghipour, Nasser Hashemi Goradel
Publikováno v:
Future oncology (London, England). 18(2)
Oncolytic virotherapy has currently emerged as a powerful therapeutic approach in cancer treatment. Although the history of using viruses goes back to the early 20th century, the approval of talimogene laherparepvec (T-VEC) in 2015 increased interest
Autor:
Mahshad Khodarahmian, Keywan Mortezae, Fardin Amidi, Neda Khanlarkhani, Elham Azizi, Maryam Shabani Nashtaei, Azar Pazhohan, Nasser Hashemi Goradel, Ensieh Salehi, Bagher Farhood
Publikováno v:
JBRA assisted reproduction. 26(2)
Ovarian cancer continues to be the leading cause of death from gynecological cancers. Despite inconsistent results, patients with metabolic abnormalities, including obesity and diabetes mellitus (DM), have poorer outcomes, showing a correlation with
Autor:
Nasser Hashemi Goradel, Dheyauldeen Shabeeb, Bagher Farhood, Keywan Mortezaee, Ahmed Eleojo Musa, Masoud Najafi, Peyman Amini
Publikováno v:
Current Molecular Pharmacology. 12:50-60
Background:Radiotherapy is a treatment modality for cancer. For better therapeutic efficiency, it could be used in combination with surgery, chemotherapy or immunotherapy. In addition to its beneficial therapeutic effects, exposure to radiation leads
Autor:
Nasser Hashemi Goradel, Maryam Mashhadi Abolghasem Shirazi, Babak Negahdari, Nasir Mohajel, Arash Arashkia, Ziba Veisi Malekshahi
Publikováno v:
International immunopharmacology. 101
The nanostructured complexes can result in enhanced vaccine efficacy by facilitating the distribution and uptake of antigens by antigen-presenting cells (APCs), thereby stimulating immune responses. Here, we hypothesized that either directly coating
Publikováno v:
Pharmacologytherapeutics. 213
Oncolytic viruses, effectively replicate viruses within malignant cells to lyse them without affecting normal ones, have recently shown great promise in developing therapeutic options for cancer. Adenoviruses (Ads) are one of the candidates in oncoly